Filing Details
- Accession Number:
- 0001021561-11-000086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-14 17:00:14
- Reporting Period:
- 2011-06-13
- Filing Date:
- 2011-06-14
- Accepted Time:
- 2011-06-14 17:00:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1021561 | Nu Skin Enterprises Inc | NUS | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 870565309 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1289557 | R Daniel Chard | C/O Nu Skin Enterprises, Inc. 75 West Center Street Provo UT 84601 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2011-06-13 | 21,250 | $9.40 | 46,841 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2011-06-13 | 17,500 | $17.25 | 64,341 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2011-06-13 | 38,750 | $35.08 | 25,591 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2011-06-13 | 21,250 | $0.00 | 21,250 | $9.40 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2011-06-13 | 17,500 | $0.00 | 17,500 | $17.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 42,500 | 2010-02-27 | 2016-02-27 | No | 4 | M | Direct |
| 0 | 2013-09-01 | No | 4 | M | Direct |
Footnotes
- Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
- Becomes exercisable in four equal annual installments beginning on the date indicated.
- Currently exercisable in full.
Billionaire Hedge Funds
